Maitreya Medicare Ltd
Diversified Consumer Services | Small Cap
Health Score : 7.34Maitreya Medicare Ltd demonstrates a mixed financial performance. The company shows strong profitability and solvency, indicating efficient management of resources and a healthy balance between debt and equity. Liquidity is also reasonably strong, suggesting the company can meet its short-term obligations. However, growth metrics are inconsistent, with revenue and asset growth contrasted by declines in operating profit and earnings per share. Efficiency ratios present a mixed picture, with high inventory turnover offset by slow collection of receivables. These factors suggest opportunities for improvement in operational efficiency and earnings consistency. Overall, the company exhibits a solid financial foundation, but needs to address areas of inconsistent growth and efficiency to enhance long-term sustainability.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio6.80
- Financial Ratio7.80
- Profitability Ratio10.00
- Efficiency Ratio5.33
- Coverage Ratio6.80
- Solvency Ratio8.40
- Liquidity Ratio8.38
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursBullish
- 4 HoursNeutral
- 1 DayBearish
- 1 WeekBearish
- 1 MonthBearish
Health Score : 7.34Maitreya Medicare Ltd demonstrates a mixed financial performance. The company shows strong profitability and solvency, indicating efficient management of resources and a healthy balance between debt and equity. Liquidity is also reasonably strong, suggesting the company can meet its short-term obligations. However, growth metrics are inconsistent, with revenue and asset growth contrasted by declines in operating profit and earnings per share. Efficiency ratios present a mixed picture, with high inventory turnover offset by slow collection of receivables. These factors suggest opportunities for improvement in operational efficiency and earnings consistency. Overall, the company exhibits a solid financial foundation, but needs to address areas of inconsistent growth and efficiency to enhance long-term sustainability.
Overall Valuation Score
P/E RATIO (TTM)
-76.94
Industry Median
47.76
Small Cap Median
45.36
P/E RATIO
-41.32
P/B RATIO
3.52
Industry Median
4.54
Small Cap Median
3.95
P/S RATIO
2.22
Industry Median
3.59
Small Cap Median
2.22
Others
PEG RATIO
0.00
EV/EBITDA RATIO
212.83
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹150.8 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Growth Score : 6.80The company exhibits mixed growth performance. While revenue and asset growth are positive, declines in operating profit and earnings per share raise concerns about profitability sustainability. Stabilizing and improving earnings growth will be critical for future investor confidence. Diversifying revenue streams can help.
Revenue Growth RateExcellent
Operating Profit Growth RatePoorEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | -11.76 | -20.41 | 17.31 | -2.39 | -0.29 |
| Operating Profit Growth Rate | -53.52 | 115.43 | -17.36 | -18.67 | -109.43 |
| Earnings Per Share (EPS) Growth | -73.11 | -99.25 | -48.89 | -36.99 | -232.25 |
| Asset Growth Rate | -3.09 | 18.05 | 51.71 | 9.44 | 42.58 |
| Net Income Growth Rate | -73.11 | 272.81 | -30.12 | -37.04 | -232.09 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Financial Score : 7.80Financial ratios indicate strong earnings per share and capital expenditure management. However, book value per share is not as high, and there are no dividends being paid. Increasing book value and considering dividends could enhance investor appeal. Efficient capital expenditure management is a positive sign.
Adjusted Earnings Per Share (Adjusted EPS)ExcellentCash Earnings Per Share (Cash EPS)ExcellentBook Value Per ShareWeakDividend Per Share (DPS)PoorCapital Expenditures (CapEx)Excellent| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 0 | 8.5 | 4.37 | 2.75 | -2.13 |
| Cash Earnings Per Share (Cash EPS) | 0 | 11.08 | 6.24 | 4.87 | -0.82 |
| Book Value Per Share | 0 | 17.54 | 36.54 | 39.29 | 25.03 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 0.9 | 0.6 | 1.6 | 2.4 | 27.1 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Profitability Score : 10.00The company's profitability ratios are excellent, showcasing efficient operations and effective cost management. High margins across various metrics indicate strong revenue generation relative to costs. Maintaining these levels of profitability ensures long-term financial health and attracts investors. Continuous improvement in profitability is vital.
Gross Profit MarginExcellentReturn on Capital Employed (ROCE)ExcellentReturn on Equity (ROE)ExcellentReturn on Assets (ROA)ExcellentOperating MarginExcellentNet MarginExcellent| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 4.15 | 15.2 | 10.26 | 7.65 | -4.41 |
| Return on Capital Employed (ROCE) | 12.33 | 32.85 | 17.3 | 10.77 | -2.18 |
| Return on Equity (ROE) | 24.2 | 48.46 | 11.95 | 7 | -8.51 |
| Return on Assets (ROA) | 13.76 | 25.11 | 13.68 | 10.17 | -0.67 |
| Operating Margin | 6.83 | 18.48 | 13.02 | 10.85 | -1.03 |
| Net Margin | 2.31 | 10.82 | 6.45 | 4.16 | -5.51 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
Efficiency Score : 5.33Efficiency ratios present a mixed picture. While inventory turnover and days sales in inventory are well-managed, fixed asset turnover and capital turnover are relatively low, and receivable days are high. Improving asset utilization and speeding up collections can significantly enhance operational efficiency. Effective management of receivables is important.
Fixed Asset Turnover RatioWeakInventory Turnover RatioExcellentReceivables Turnover RatioWeakDays Sales in Inventory RatioExcellentReceivable DaysPoorCapital Turnover RatioPoor| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 3.68 | 3.39 | 3.22 | 2.95 | 1.1 |
| Inventory Turnover Ratio | 45.92 | 44.71 | 58.65 | 69.23 | 65.5 |
| Receivables Turnover Ratio | 9.17 | 5.04 | 3.93 | 3.14 | 3.45 |
| Days Sales in Inventory Ratio | 7.95 | 8.16 | 6.22 | 5.27 | 5.57 |
| Receivable Days | 39.8 | 72.42 | 92.88 | 116.24 | 105.8 |
| Capital Turnover Ratio | 4.5 | 2.7 | 1.58 | 1.48 | 0.88 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
Coverage Score : 6.80The company's coverage ratios show a strong ability to cover interest expenses but no dividend coverage. A solid interest coverage ratio indicates low risk related to debt obligations. The absence of dividend coverage may be a strategic decision to reinvest earnings. Maintaining a healthy interest coverage is important.
Interest Coverage RatioExcellentEquity Dividend Coverage RatioPoor| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 3.05 | 11.4 | 5.99 | 5.01 | -0.67 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
Solvency Score : 8.40The company's solvency position is strong, suggesting a stable financial structure. The debt and debt-to-equity ratios are reasonable, indicating a balanced use of debt and equity. A good equity ratio further supports the financial stability of the company. Prudent management of debt ensures long-term financial health.
Debt RatioGoodDebt to Equity RatioGoodEquity RatioGoodDebt To Asset RatioExcellent| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.7 | 0.57 | 0.28 | 0.25 | 0.43 |
| Debt to Equity Ratio | 2.33 | 1.33 | 0.39 | 0.33 | 0.75 |
| Equity Ratio | 0.3 | 0.43 | 0.72 | 0.75 | 0.57 |
| Debt To Asset Ratio | 0.45 | 0.4 | 0.22 | 0.19 | 0.32 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
Liquidity Score : 8.38The company's liquidity position is generally strong, indicating a good ability to meet its short-term obligations. High current and quick ratios suggest the company has sufficient liquid assets. However, the operating cash flow ratio is weak, which could be a point of concern if not managed well. Maintaining a healthy cash ratio supports day-to-day operations.
Current RatioExcellentQuick RatioExcellentCash RatioGoodOperating Cash Flow RatioWeak| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.25 | 1.93 | 3.03 | 2.65 | 1.58 |
| Quick Ratio | 1.17 | 1.84 | 2.96 | 2.61 | 1.53 |
| Cash Ratio | 0.13 | 0.23 | 0.71 | 0.64 | 0.5 |
| Operating Cash Flow Ratio | 0.01 | 0.3 | -0.27 | 0.41 | 0.48 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Maitreya Medicare Ltd | 7.34 | -41.32 | Neutral | -0.46 | -1.96 | -2.47 |
| 2 | Sangani Hospitals Ltd | 7.21 | 20.32 | Neutral | 8.00 | 1.74 | 4.00 |
| 3 | Lotus Eye Hospital & Institute Ltd | 6.07 | 328.53 | Overvalued | 3.38 | 0.04 | 0.08 |
| 4 | Nephro Care India Ltd | 5.69 | 33.26 | Neutral | 8.32 | 2.04 | 3.37 |
Balanced ManagementThe management effectiveness of Maitreya Medicare Ltd presents a mixed picture. While the company demonstrates a high promoter holding, aligning management and shareholder interests, there are concerns regarding profitability and sales growth. Profit growth over the past three years has not translated into recent profitability, and sales growth has been inconsistent. The company also exhibits a high P/E ratio relative to peers, suggesting overvaluation. Prudent financial management is evident in controlled debt levels, but declining returns indicate areas for operational improvement.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Promoter Holding | 73.11% | Strong alignment with shareholder interests |
| CONS | Compounded Profit Growth (TTM) | -40% | Declining profitability |
| Sales Growth (3Y) | -2% | Sales growth is degrowing | |
| High P/E Ratio | 104 | High valuation compared to Median P/E of peers 61.11 |
Financial Performance & GrowthAverageCapital Efficiency & ReturnsAverageFinancial Health & PrudenceGoodShareholding & Ownership StructureExcellentFinancial Performance & Growth
Maitreya Medicare demonstrates inconsistent financial performance. Sales Growth has been volatile, with a 17.44% increase in Mar 2024 followed by a modest 1.15% increase in Mar 2025. The compounded sales growth over the past 3 years is -2%, and TTM sales growth is 1%. Profitability has also fluctuated, with the compounded profit growth of 20% over the past 3 years but a concerning -40% TTM. OPM has varied, from 18.39% in Sep 2023 to 7.53% in Mar 2025. The inconsistency in sales and profitability metrics suggests potential instability in the company's financial performance.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Sales Growth % | -11.76% | -20.41% | 17.44% | 1.15% | |
| OPM % | 12.96% | 6.83% | 18.48% | 13.44% | 10.42% |
Capital Efficiency & Returns
The capital efficiency and returns of Maitreya Medicare show mixed results. The ROCE has decreased from 32.85% in Mar 2023 to 10.82% in Mar 2025, indicating a decline in the efficiency of capital utilization. The Cash Conversion Cycle (CCC) has shifted from negative values to 7.44 days in Mar 2025, suggesting less efficient working capital management. ROE is not available for all periods, limiting a comprehensive assessment of shareholder returns.These trends suggest that the company's ability to generate returns from its capital has diminished, and working capital management needs improvement.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| ROCE % | 12.33% | 32.85% | 18.00% | 10.82% | |
| Cash Conversion Cycle | -157.37 | -137.61 | -159.32 | -58.59 | 7.44 |
Financial Health & Prudence
Maitreya Medicare demonstrates reasonable financial health and prudence. The company maintains controlled debt levels, with Borrowings decreasing from ₹14.24 Cr in Mar 2021 to ₹5.20 Cr in Mar 2025. The Debt/Equity ratio cannot be calculated due to missing data, but the reduction in borrowings indicates a positive trend. The company has not been paying dividends, as the Dividend Payout % is 0.00% across all reported years. This indicates that the company is retaining earnings for reinvestment or other purposes.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Borrowings (Cr) | 14.24 | 12.38 | 11.59 | 11.10 | 5.20 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Shareholding & Ownership Structure
Maitreya Medicare exhibits a strong shareholding and ownership structure. Promoter holding remains consistently high at 73.11% from Mar 2024 to Mar 2025, indicating strong confidence and alignment with shareholders. However, FII holdings have decreased significantly from 2.53% in Mar 2024 to 0.01% in Mar 2025, and DII holdings have dropped to 0.00% in Mar 2025. The increase in the number of shareholders from 474 in Mar 2024 to 986 in Mar 2025 shows a growing public interest in the company.
| Metric | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|
| Promoters + | 73.11% | 73.11% | 73.11% |
| FIIs + | 2.53% | 0.41% | 0.01% |
| DIIs + | 1.35% | 0.00% | 0.00% |
| Public + | 23.02% | 26.48% | 26.88% |
| No. of Shareholders | 474 | 907 | 986 |
Balanced RiskMaitreya Medicare's risk profile is moderate. The key risks include fluctuating profitability and sales growth, as well as declining returns on capital employed. The company's reliance on a few key segments could amplify the impact of any downturn in those areas. However, the company benefits from a high level of promoter holding, indicating strong management commitment. Prudent debt management also mitigates financial risk.
Segment performance volatilityAverageForeign exchange or interest rate exposureAverageSegment performance volatility
The quarterly results for Maitreya Medicare show volatility in segment performance. Sales figures fluctuate, with a decrease from ₹24.79 in Sep 2023 to ₹22.30 in Mar 2025. Operating Profit Margin (OPM) also varies, ranging from 18.39% in Sep 2023 to 5.04% in Mar 2024. Net Profit shows significant swings, from ₹2.56 in Sep 2023 to ₹0.09 in Mar 2024.
| Metric | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales | 24.79 | 23.01 | 24.36 | 22.30 |
| OPM % | 18.39% | 5.04% | 13.05% | 7.53% |
| Net Profit | 2.56 | 0.09 | 1.67 | 0.20 |
Foreign exchange or interest rate exposure
The interest expenses for Maitreya Medicare have been relatively stable, ranging from ₹0.39 Cr in Sep 2023 to ₹0.35 Cr in Mar 2025. This suggests that the company's exposure to interest rate fluctuations is manageable. However, the company's financial statements do not provide specific data on foreign exchange exposure, making it difficult to assess the risks associated with currency fluctuations.
| Metric | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|
| Interest (Cr) | 0.39 | 0.46 | 0.45 | 0.35 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10147.53Bullish
- SMA 20147.65Bullish
- SMA 50149.63Bullish
- EMA 10148.09Bullish
- EMA 20147.87Bullish
- EMA 50150.06Bullish
- DEMA 10148.89Bullish
- DEMA 20147.42Bullish
- DEMA 50145.26Bullish
- TEMA 10149.77Bullish
- TEMA 20148.55Bullish
- TEMA 50146.09Bullish
- MACD-0.16Bullish
- ADX16.83Weak Trend
- IndicatorValueSignal
- RSI56.93Neutral
- CCI119.25Overbought
- ROC 93.75Bullish
- ROC 141.67Bullish
- ROC 2511.76Bullish
- Stoch K51.11Neutral
- Stoch D29.67Neutral
- IndicatorValueSignal
- BB Upper152.38Neutral
- BB Middle147.65Neutral
- BB Lower142.92Neutral
- ATR2.54Low Volatility
- IndicatorValueSignal
- MFI77.24Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10147.72Bullish
- SMA 20148.01Bullish
- SMA 50153.52Bearish
- EMA 10148.02Bullish
- EMA 20148.75Bullish
- EMA 50153.56Bearish
- DEMA 10148.22Bullish
- DEMA 20146.31Bullish
- DEMA 50145.63Bullish
- TEMA 10149.54Bullish
- TEMA 20147.44Bullish
- TEMA 50144.54Bullish
- MACD-1.58Bullish
- ADX20.54Weak Trend
- IndicatorValueSignal
- RSI53.17Neutral
- CCI52.73Neutral
- ROC 91.67Bullish
- ROC 147.38Bullish
- ROC 25-1.30Bearish
- Stoch K65.30Neutral
- Stoch D50.16Neutral
- IndicatorValueSignal
- BB Upper156.13Neutral
- BB Middle148.01Neutral
- BB Lower139.88Neutral
- ATR4.23Low Volatility
- IndicatorValueSignal
- MFI42.59Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10147.31Bullish
- SMA 20150.42Bullish
- SMA 50162.62Bearish
- EMA 10148.31Bullish
- EMA 20151.25Bullish
- EMA 50160.06Bearish
- DEMA 10146.50Bullish
- DEMA 20144.97Bullish
- DEMA 50148.05Bullish
- TEMA 10147.98Bullish
- TEMA 20145.09Bullish
- TEMA 50N/AN/A
- MACD-4.43Bullish
- ADX10.29Weak Trend
- IndicatorValueSignal
- RSI48.45Neutral
- CCI-31.60Neutral
- ROC 9-1.27Bearish
- ROC 14-3.31Bearish
- ROC 25-9.47Bearish
- Stoch K39.58Neutral
- Stoch D37.16Neutral
- IndicatorValueSignal
- BB Upper160.16Neutral
- BB Middle150.42Neutral
- BB Lower140.67Neutral
- ATR7.43Low Volatility
- IndicatorValueSignal
- MFI50.86Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 10152.75Bearish
- SMA 20160.89Bearish
- SMA 50170.23Bearish
- SMA 100187.64Bearish
- SMA 200218.56Bearish
- EMA 10152.84Bearish
- EMA 20158.76Bearish
- EMA 50170.77Bearish
- EMA 100187.38Bearish
- EMA 200210.86Bearish
- DEMA 10146.45Bullish
- DEMA 20149.36Bearish
- DEMA 50153.07Bearish
- DEMA 100157.44Bearish
- DEMA 200177.68Bearish
- TEMA 10145.51Bullish
- TEMA 20146.76Bearish
- TEMA 50151.59Bearish
- TEMA 100151.35Bearish
- TEMA 200158.94Bearish
- MACD-7.32Bearish
- ADX20.91Weak Trend
- IndicatorValueSignal
- RSI37.22Neutral
- CCI-106.62Oversold
- ROC 14-11.21Bearish
- ROC 25-19.90Bearish
- Stoch K26.66Neutral
- Stoch D28.12Neutral
- IndicatorValueSignal
- BB Upper180.06Neutral
- BB Middle160.89Neutral
- BB Lower141.72Neutral
- ATR11.27Low Volatility
- IndicatorValueSignal
- MFI19.26Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20183.34Bearish
- SMA 50220.81Bearish
- EMA 20182.67Bearish
- EMA 50211.29Bearish
- DEMA 20157.68Bearish
- DEMA 50181.87Bearish
- TEMA 20154.60Bullish
- TEMA 50N/AN/A
- MACD-18.55Bearish
- ADX10.14Weak Trend
- IndicatorValueSignal
- RSI37.81Neutral
- CCI-146.42Oversold
- ROC 14-28.37Bearish
- ROC 25-30.48Bearish
- Stoch K9.33Oversold
- Stoch D12.77Oversold
- IndicatorValueSignal
- BB Upper220.80Neutral
- BB Middle183.34Neutral
- BB Lower145.89Neutral
- ATR25.10Low Volatility
- IndicatorValueSignal
- MFI30.56Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6188.76Bearish
- SMA 12217.40Bearish
- SMA 24249.82Bearish
- EMA 6189.48Bearish
- EMA 12209.32Bearish
- EMA 24218.15Bearish
- DEMA 6166.68Bearish
- DEMA 12184.82Bearish
- DEMA 24N/AN/A
- TEMA 6163.40Bullish
- TEMA 12N/AN/A
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX16.92Weak Trend
- IndicatorValueSignal
- RSI50.93Neutral
- CCIN/AN/A
- ROC 25-7.22Bearish
- ROC 50N/AN/A
- Stoch KN/AN/A
- Stoch DN/AN/A
- IndicatorValueSignal
- BB Upper360.60Neutral
- BB Middle253.44Neutral
- BB Lower146.28Neutral
- ATR59.97Low Volatility
- IndicatorValueSignal
- MFI28.65Neutral